Skip to content
Pre-Order

 

 

 

 

 

Science with Purpose

Murnia was founded by a team with over 35 years of biotech R&D experience and a clear philosophy: effective solutions must also be clean, safe and simple to use.

Having witnessed firsthand the devastating impact of cancer treatment side effects, we first focused on preventing severe wounds from Oral Mucositis and Radiodermatitis. Our mission has always been to protect, soothe, and restore the health of skin and mucosa for everyone facing difficult health challenges—and our product solutions continue to expand from there.

Our goals: Better patient outcomes. Improved quality of life. Reduced healthcare costs. Wellness and healthy looking skin — inside and out.

Innovation to prevent severe cancer wounds

Cancer patient 1

Starting point of Murnia™ was a focus on severe cancer wounds to improve outcomes and quality of life. Powered by innovative molecular compound, Murnia™ solutions showed strong prevention effects in trials presented at international oncology congresses.

ORAL MUCOSITIS - Double Blind Placebo Controlled Clinical Trial (H&N Cancer Patients)

  • No Grade 3/4 progression in Murnia cohort.
  • No break in treatment.
  • No opioids or side effects. 

RADIODERMATITIS Observational Study - (Radiotherapy Patients)

  • <12% progression to Grade 3, a significant reduction. 
Download Oral Mucositis Poster
Download Radiodermatitis Poster

Awards

Image of oral mucosa

Murnia™ Molecular Compound

  • Adhesive properties

  • Natural pain soothing effect of sesquiterpenes, rich in compound.

  • Antimicrobial, antiviral, anti-fungal properties demonstrated via testing.

  • 69% antioxidant effect.

  • Supporting skin's natural regenerative process via speeding up synthesis of essential elements like Collagen, Elastin, TGFβ1, HAS3.
Learn more

Contact Murnia™ Team

Have questions about our NEW Murnia™ Mouth Spray, or want to find out more about our history, portfolio of products available and under development?